| Drug Type Small molecule drug | 
| Synonyms Caffenelin, 원라인세미정, 카펜에린정 | 
| Action agonists, antagonists, inhibitors | 
| Mechanism A1R agonists(Adenosine A1 receptor agonists), A2aR antagonists(Adenosine A2a receptor antagonists), Adenosine receptor antagonists + [3] | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhaseApproved | 
| First Approval Date South Korea (01 Oct 2021),  | 
| Regulation- | 
| Molecular FormulaC10H15NO | 
| InChIKeyKWGRBVOPPLSCSI-WPRPVWTQSA-N | 
| CAS Registry299-42-3 | 
| Indication | Country/Location | Organization | Date | 
|---|---|---|---|
| Common Cold | South Korea  | 01 Oct 2021 | 





